Citation: J. Li et al., Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation, MOLEC PHARM, 60(5), 2001, pp. 1064-1075
Authors:
Huang, P
Kehner, GB
Cowan, A
Liu-Chen, LY
Citation: P. Huang et al., Comparison of pharmacological activities of buprenorphine and norbuprenorphine: Norbuprenorphine is a potent opioid agonist, J PHARM EXP, 297(2), 2001, pp. 688-695
Citation: Xh. Chen et al., Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin, BRAIN RES, 904(2), 2001, pp. 252-258
Authors:
Huang, P
Li, J
Chen, CG
Visiers, I
Weinstein, H
Liu-Chen, LY
Citation: P. Huang et al., Functional role of a conserved motif in TM6 of the rat mu opioid receptor:Constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp, BIOCHEM, 40(45), 2001, pp. 13501-13509
Authors:
Li, J
Huang, P
Chen, CG
de Riel, JK
Weinstein, H
Liu-Chen, LY
Citation: J. Li et al., Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression, BIOCHEM, 40(40), 2001, pp. 12039-12050
Authors:
Xu, W
Li, J
Chen, CG
Huang, P
Weinstein, H
Javitch, JA
Shi, L
de Riel, JK
Liu-Chen, LY
Citation: W. Xu et al., Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors, BIOCHEM, 40(27), 2001, pp. 8018-8029
Authors:
Aicher, SA
Sharma, S
Cheng, PY
Liu-Chen, LY
Pickel, VM
Citation: Sa. Aicher et al., Dual ultrastructural localization of mu-opiate receptors and substance P in the dorsal horn, SYNAPSE, 36(1), 2000, pp. 12-20
Authors:
McFadyen, IJ
Houshyar, H
Liu-Chen, LY
Woods, JH
Traynor, JR
Citation: Ij. Mcfadyen et al., The steroid 17 alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,5-dien-20-one (SC17599) is a selective mu-opioid agonist: Implicationsfor the mu-opioid pharmacophore, MOLEC PHARM, 58(4), 2000, pp. 669-676
Citation: Jg. Li et al., Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: Internalization is required for down-regulation, MOLEC PHARM, 58(4), 2000, pp. 795-801
Citation: Cv. Carman et al., Mutational analysis of G beta gamma and phospholipid interaction with G protein-coupled receptor kinase 2, J BIOL CHEM, 275(14), 2000, pp. 10443-10452
Authors:
Xu, W
Chen, CG
Huang, P
Li, J
de Riel, JK
Javitch, JA
Liu-Chen, LY
Citation: W. Xu et al., The conserved cysteine 7.38 residue is differentially accessible in the binding-site crevices of the mu, delta, and kappa opioid receptors, BIOCHEM, 39(45), 2000, pp. 13904-13915
Authors:
Li, JG
Chen, CG
Yin, JL
Rice, K
Zhang, Y
Matecka, D
de Riel, JK
DesJarlais, RL
Liu-Chen, LY
Citation: Jg. Li et al., Asp147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone, LIFE SCI, 65(2), 1999, pp. 175-185
Citation: Jg. Li et al., U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism - kappa receptor internalization is not required for mitogen-activated protein kinase activation, J BIOL CHEM, 274(17), 1999, pp. 12087-12094
Authors:
Xu, W
Ozdener, F
Li, JG
Chen, CG
de Riel, JK
Weinstein, H
Liu-Chen, LY
Citation: W. Xu et al., Functional role of the spatial proximity of Asp114(2.50) in TMH2 and Asn332(7.49) in TMH7 of the mu opioid receptor, FEBS LETTER, 447(2-3), 1999, pp. 318-324
Authors:
Alicea, C
Belkowski, SM
Sliker, JK
Zhu, JM
Liu-Chen, LY
Eisenstein, TK
Adler, MW
Rogers, TJ
Citation: C. Alicea et al., Characterization of kappa-opioid receptor transcripts expressed by T cellsand macrophages, J NEUROIMM, 91(1-2), 1998, pp. 55-62